Clinical measurement of blood flow in tumours using positron emission tomography: a review.
AffiliationCRC PET Oncology Group, MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Rd, London W12 0NN, UK.
MetadataShow full item record
AbstractIn oncology drug development there is an increasing need for the in vivo physiological measurement of changes in tumour blood flow in response to therapy. Positron Emission Tomography (PET) is being increasingly used in oncology patients to measure blood flow. Here we review the clinical use of PET to measure vascular parameters in man.
CitationClinical measurement of blood flow in tumours using positron emission tomography: a review. 2002, 23 (2):131-8 Nucl Med Commun
JournalNuclear Medicine Communications
- Measurement of local cerebral blood flow and metabolism in man with positron emission tomography.
- Authors: Raichle ME
- Issue date: 1981 Jun
- Perfusion quantitation using positron emission tomography.
- Authors: Hoffman JM, Coleman RE
- Issue date: 1992 Dec
- Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer.
- Authors: Wilson CB, Snook DE, Dhokia B, Taylor CV, Watson IA, Lammertsma AA, Lambrecht R, Waxman J, Jones T, Epenetos AA
- Issue date: 1991 Feb 1
- Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma.
- Authors: Beaney RP, Lammertsma AA, Jones T, McKenzie CG, Halnan KE
- Issue date: 1984 Jan 21
- Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
- Authors: Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF
- Issue date: 2002 Jan 15